Our Research
The primary research focus of scientists working in the Microbial Proteomics Research Group is on the human pathogens Staphylococcus aureus and Pseudomonas aeruginosa. These bacteria are among the most feared human pathogens worldwide that are responsible for more than half of all hospital infections. Particularly alarming in this context is the growing number of infections with multi-resistant strains that do not respond to treatment with conventional antibiotics and thus frequently lead to death of a patient.
This is why it is important that new treatment strategies for these pathogens have to be developed that can readily be implemented in the clinical setting. To this end, an in-depth knowledge of these pathogens´ pathophysiology and virulence is urgently warranted – which is the reason why our scientists are specifically looking at identifying the link between the pathogens´ physiology and its knack for colonizing its host and causing disease.
The true effectors inside a cell are proteins. As these proteins are key to the bacterium's interaction with its host, HZI scientists are not only interested in a systematic investigation of protein synthesis and degradation in bacterial cells, but they are also trying to shed light on these molecules' activity and modifications and on the jobs they perform. In particular, they focus on very small proteins with up to 100 amino acids that are still rarely characterized.
In order to document and study the total of bacterial proteins under pre-specified conditions and at specific points in time within a closed system, our scientists are drawing on a range of different research tools based on mass spectrometry. Using appropriate methods of preparation, proteins are assigned to specific cellular compartments and quantified.
This way, cytoplasmic proteins can be easily distinguished from membrane and surface bound or even secretory proteins. Any change in terms of quantity or type of modification can be analyzed.
Our researchers use these tools to study the regulation and function of bacterial proteins involved in host adaptation for identifying potential new virulence determinants and their targets in the host. They are looking at how S. aureus and P. aeruginosa adapt to situations of stress and starvation and to exposure to antibiotics and which proteins are essential for these processes. Another research focus is on development of new methods and algorithms for predicting and identifying small proteins in bacteria.
Our Research
The primary research focus of scientists working in the Microbial Proteomics Research Group is on the human pathogens Staphylococcus aureus and Pseudomonas aeruginosa. These bacteria are among the most feared human pathogens worldwide that are responsible for more than half of all hospital infections. Particularly alarming in this context is the growing number of infections with multi-resistant strains that do not respond to treatment with conventional antibiotics and thus frequently lead to death of a patient.
This is why it is important that new treatment strategies for these pathogens have to be developed that can readily be implemented in the clinical setting. To this end, an in-depth knowledge of these pathogens´ pathophysiology and virulence is urgently warranted – which is the reason why our scientists are specifically looking at identifying the link between the pathogens´ physiology and its knack for colonizing its host and causing disease.
The true effectors inside a cell are proteins. As these proteins are key to the bacterium's interaction with its host, HZI scientists are not only interested in a systematic investigation of protein synthesis and degradation in bacterial cells, but they are also trying to shed light on these molecules' activity and modifications and on the jobs they perform. In particular, they focus on very small proteins with up to 100 amino acids that are still rarely characterized.
In order to document and study the total of bacterial proteins under pre-specified conditions and at specific points in time within a closed system, our scientists are drawing on a range of different research tools based on mass spectrometry. Using appropriate methods of preparation, proteins are assigned to specific cellular compartments and quantified.
This way, cytoplasmic proteins can be easily distinguished from membrane and surface bound or even secretory proteins. Any change in terms of quantity or type of modification can be analyzed.
Our researchers use these tools to study the regulation and function of bacterial proteins involved in host adaptation for identifying potential new virulence determinants and their targets in the host. They are looking at how S. aureus and P. aeruginosa adapt to situations of stress and starvation and to exposure to antibiotics and which proteins are essential for these processes. Another research focus is on development of new methods and algorithms for predicting and identifying small proteins in bacteria.
Susanne Engelmann studied biology at the University of Greifswald, earning her Ph.D. at the Institute for Microbiology. In 2001, she became head of the Pathogenomics research unit at the University of Greifswald Institute for Microbiology and, in 2013, was appointed Professor of Microbial Proteome Research at Braunschweig University of Technology. Concurrently, she also holds an appointment as head of the HZI’s Microbial Proteomics Research Group.
Team
Alumni
- Dr. Julia Bosselmann, Research Associate
- Christian Ebenhög, MSc Chemistry
- Malina Hase, BSc Biology
- Ellen Elsner, BSc Biotechnology
- Simon Klute, BSc Biology
- Katharina Hübscher, BSc Biology
- Piotr Stanczyk, BSc Biotechnology
- Janik Melcher, BSc Biology
- Kimberly Borkiert, MSc Biology
- Gazal Gökkus, BSc Biology
- Erik Lehmann, PhD
- Melina Lieder, MSc Molecular Medicine
- Kim Jana Lüttker, Food Chemistry
- Alicia Klaude, MSc Biochemistry/Chemical Biology
- Dominique Werner, BSc Biology
- Annette Hasel, MSc Biochemistry/Chemical Biology
- Maya Wilkens, MSc Biology
- Ayten Mustafayeva, MSc Biology
- Mandy Meinert, BSc Biotechnology
- Dr. Peggy Kloppot, research associate
- Martin Lietz, food chemistry
- Jan Schob, MSc Biology
- Steffen Günzel, BSc Biology
- Kaja Kleinteich, BSc Biology
- Manuela Fuchs, BSc Biology
- Tobias Ludwig, MSc Biology
- Frerich Masson, BSc Biology
- Bastian Kruse, BSc Biology
Selected Publications
Fuchs, S., M. Kucklick, E. Lehmann, A. Beckmann, M. Wilkens, B. Kolte, A. Mustafayeva, T. Ludwig, M. Diwo, J. Wissing, L. Jänsch, C.H. Ahrens, Z. Ignatova, and S. Engelmann. 2021. Towards the characterization of the hidden world of small proteins in Staphylococcus aureus, a proteogenomics approach. PloS Genetics. 17(6):e1009585. doi: 10.1371/journal.pgen.1009585.
Bartholomäus, A., B. Kolte, A. Mustafayeva, I. Goebel, S. Fuchs, D. Benndorf, S. Engelmann, Z. Ignatova. 2021. smORFer: a modular algorithm to detect small ORFs in prokaryotes. Nuc. Acid Res. 49:e89. doi: 10.1093/nar/gkab477.
Pagels M., Fuchs S., Pané-Farré J., Kohler C., Menschner L., Hecker M., McNamarra P.J., Bauer M.C., von Wachenfeldt C., Liebeke M., Lalk M., Sander G., von Eiff C., Proctor R.A., Engelmann S. (2010) Redox sensing by a Rex-family repressor is involved in the regulation of anaerobic gene expression in S. aureus. Mol Microbiol 76:1142-1161.
Selle M., Hertlein T., Oesterreich B., Klemm T., Kloppot P., Müller E., Ehricht R., Stentzel S., Bröker B.M., Engelmann S., Ohlsen K. (2016) Global antibody response to S. aureus live-cell vaccination. Sci Rep 6:24754.
Boedeker C., Schüler M., Reintjes G., Jeske O., van Teeseling M., Jogler M., Rast P., Borchert D., Devos D.P., Kucklick M., Schaffer M., Kolter R., van Niftrik L., Engelmann S., Amann R., Rhode M., Engelhardt H., Jogler C. (2017) Determining the bacterial cell biology of Planctomycetes. Nat Commun 8:14853.